The combination of fludarabine and intravenous busulfan (IVFB) has a more favorable toxicity profile and overall outcome than fludarabine and melphalan (FM) as reduced-intensity conditioning prior to allogeneic stem-cell transplantation (SCT)

被引：0
|
作者：
Shimoni, A [1 ]
Yeshurun, M [1 ]
Hardan, I [1 ]
Shem-Tov, N [1 ]
Avigdor, A [1 ]
Ben-Bassat, I [1 ]
Nagler, A [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
EXPERIMENTAL HEMATOLOGY | 2004年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies
    Shimoni, Avichai
    Hardan, Izhar
    Rand, Avital
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2007, 110 (11) : 596A - 596A
  • [2] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
  • [3] Intravenous busulfan versus melphalan-based low intensity conditioning prior to allogeneic stem-cell transplantation: Lower TRM and a more favorable toxicity profile
    Shimoni, A
    Hardan, I
    Yeshurun, M
    Avigdor, A
    Papatryphonos, A
    Tsolakis, FI
    Nagler, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 34 - 34
  • [4] Impact of age on outcome of reduced-intensity conditioning with fludarabine and busulfan for allogeneic haematopoietic cell transplantation
    Schneidawind, D.
    Federmann, B.
    Helwig, A.
    Vogel, W.
    Faul, C.
    Kanz, L.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S230 - S230
  • [5] Intravenous busulfan versus melphalan-based reduced-intensity conditioning prior to allogeneic stem cell transplantation: lower TRM and a more favourable toxicity profile
    Shimoni, A
    Hardan, I
    Yeshurun, M
    Avigdor, A
    Papatryphonos, A
    Tsolakis, F
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S12 - S13
  • [6] Fludarabine, Low Dose Busulfan and Antithymocyte Globulin for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT)
    Malard, F.
    Brissot, Eolia
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Le Gouill, Steven
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harousseau, Jean-Luc
    Moreau, Philippe
    Milpied, Noel-Jean
    Mohty, Mohamad
    BLOOD, 2009, 114 (22) : 1296 - 1297
  • [7] Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
    Jain, Tania
    Alandab, Fares
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Almader-Douglas, Diana
    Palmer, Jeanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 728 - 733
  • [8] Reduced-intensity conditioning with fludarabine, low-dose busulfan and antithymocyte globulin prior to allogeneic stem cell transplantation
    Malard, F.
    Brissot, E.
    Delaunay, J.
    Ayari, S.
    Guillaume, T.
    Chevallier, P.
    Dubruille, V.
    Mahe, B.
    Blin, N.
    Gastinne, T.
    Le Gouill, S.
    Saulquin, B.
    Harousseau, J. L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S290 - S290
  • [9] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Takuya Yamashita
    Akiyoshi Takami
    Naoyuki Uchida
    Takahiro Fukuda
    Tetsuya Eto
    Souichi Shiratori
    Shuichi Ota
    Takashi Akasaka
    Shigesaburo Miyakoshi
    Tadakazu Kondo
    Michihiro Hidaka
    Junya Kanda
    Yoshiko Atsuta
    Shingo Yano
    Bone Marrow Transplantation, 2020, 55 : 1955 - 1965
  • [10] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Yamashita, Takuya
    Takami, Akiyoshi
    Uchida, Naoyuki
    Fukuda, Takahiro
    Eto, Tetsuya
    Shiratori, Souichi
    Ota, Shuichi
    Akasaka, Takashi
    Miyakoshi, Shigesaburo
    Kondo, Tadakazu
    Hidaka, Michihiro
    Kanda, Junya
    Atsuta, Yoshiko
    Yano, Shingo
    BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 1955 - 1965
12345